Intelligent Bio Solutions (INBS) Common Equity (2019 - 2025)

Intelligent Bio Solutions' Common Equity history runs 7 years deep, the most recent figure standing at $2.8 million for Q2 2025.

• In Q2 2025, Common Equity fell 65.61% year-over-year to $2.8 million; the TTM figure through Jun 2025 stood at $2.8 million (down 65.61% YoY), while the FY2025 annual figure was $2.8 million, down 65.61% from the prior year.
• Common Equity was $2.8 million for Q2 2025 at Intelligent Bio Solutions, down from $4.9 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $15.9 million in Q1 2021 to a low of $1.2 million in Q3 2023.
• Historically, Common Equity has averaged $7.6 million across 5 years, with a median of $6.2 million in 2022.
• The sharpest annual moves came in 2021 and 2023: Common Equity soared 543.02% in 2021, then plunged 76.2% in 2023.
• A 5-year view of Common Equity shows it stood at $10.0 million in 2021, then advanced by 2.17% to $10.3 million in 2022, then plunged by 69.27% to $3.2 million in 2023, then surged by 33.26% to $4.2 million in 2024, then tumbled by 33.06% to $2.8 million in 2025.
• The last three Common Equity figures came in at $2.8 million (Q2 2025), $4.9 million (Q1 2025), and $4.2 million (Q4 2024), per Business Quant data.